Latest Breaking News On - Immunovant inc - Page 24 : comparemela.com

Immunovant (NASDAQ:IMVT) Price Target Raised to $47 00

Immunovant (NASDAQ:IMVT – Free Report) had its target price hoisted by HC Wainwright from $29.00 to $47.00 in a report published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Immunovant’s Q3 2024 earnings at ($0.55) EPS, Q4 2024 earnings at ($0.55) EPS, FY2024 […]

Marks levineRaymond jamesImmunovant company profileHermes incSciences ltdImmunovant incCantor fitzgeraldVictory capital management incPerceptive advisorsSecurities exchange commissionWells fargo companyFree reportGet free reportDirector sciencesExchange commissionStreet corp

HC Wainwright Boosts Immunovant (NASDAQ:IMVT) Price Target to $47 00

Immunovant (NASDAQ:IMVT – Free Report) had its price target boosted by HC Wainwright from $29.00 to $47.00 in a research report released on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Immunovant’s Q3 2024 earnings at ($0.55) EPS, Q4 2024 earnings at ($0.55) EPS, […]

Raymond jamesStifel nicolausPeter salzmannWells fargo companyCantor fitzgeraldImmunovant incSciences ltdHermes incPerceptive advisorsSecurities exchange commissionVictory capital management incFree reportGet free reportDirector sciencesExchange commissionStreet corp

Immunovant (NASDAQ:IMVT) Price Target Raised to $45 00 at Cantor Fitzgerald

Immunovant (NASDAQ:IMVT – Free Report) had its price target hoisted by Cantor Fitzgerald from $30.00 to $45.00 in a report issued on Monday, Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts have also commented on the stock. UBS Group upgraded shares of Immunovant from a neutral […]

Eva renee barnettRaymond jamesCantor fitzgeraldBlackrock incImmunovant company profileSwiss national bankSciences ltdMetlife investment managementImmunovant incJpmorgan chase coWells fargo companyDimensional fund advisorsFree reportWells fargoTrading downGet free report

Ginkgo Bioworks (NYSE:DNA) and Immunovant (NASDAQ:IMVT) Financial Survey

Ginkgo Bioworks (NYSE:DNA) and Immunovant (NASDAQ:IMVT) Financial Survey
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkRoivant sciences ltdGinkgo bioworks holdings incImmunovant incGinkgo bioworksGet free reportGiven ginkgo bioworkBioworks holdingsRoivant sciencesGinkgo bioworks daily

Ginkgo Bioworks (NYSE:DNA) & Immunovant (NASDAQ:IMVT) Financial Contrast

Ginkgo Bioworks (NYSE:DNA) & Immunovant (NASDAQ:IMVT) Financial Contrast
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesGinkgo bioworks holdings incImmunovant incRoivant sciences ltdGinkgo bioworksGet free reportGiven ginkgo bioworkBioworks holdingsRoivant sciencesGinkgo bioworks daily